Jennifer N. K. Nyarko

The Aβ(1–38) peptide is a negative regulator of the Aβ(1–42) peptide implicated in Alzheimer disease progression

Maa O. Quartey, Jennifer N. K. Nyarko, Jason Maley et al. · Scientific Reports · 2021 · 54 citations · Full text

Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex

Maa O. Quartey, Jennifer N. K. Nyarko, Paul R. Pennington et al. · Frontiers in Neuroscience · 2018 · 49 citations · Full text

Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease

Jennifer N. K. Nyarko, Maa O. Quartey, Paul R. Pennington et al. · Neuroscience · 2018 · 40 citations · Full text

Neurochemical Biomarkers, Social Sciences, Alzheimer's Disease +18

The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line

Tamara Satram-Maharaj, Jennifer N. K. Nyarko, Kelly Kuski et al. · Cellular Signalling · 2014 · 33 citations

Breast Oncology, Breast Cancer, Cell Biology +6

Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples

Jennifer N. K. Nyarko, Maa O. Quartey, Ryan M. Heistad et al. · Frontiers in Neuroscience · 2018 · 14 citations · Full text